Skip to content

Evaluation of early and intermediate outcomes of Cryo-Maze procedure on atrial fibrillation

Outcomes of Cryo-Maze on atrial fibrillation

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201108187325N2
Enrollment
2011
Registered
2012-07-13
Start date
2009-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

af. Fibrillation - atrial or auricular (established) I48

Interventions

All patients admitted electively in surgery center and were visited by anesthesiologist associates. History of drug used was investigated. In patients who were taking warfarin, warfarin was stopped th
the professor and co-operative by his assistant (flow of cardiovascular surgery) operation time, cardiopulmonary bypass (CPB) and long-term clamp time and any complications were monitored and recorded
Treatment - Surgery

Sponsors

Vice Chancellor, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients with atrial arrhythmia rhythm whom have coronary artery bypass graft were enrolled in this study. Patients' satisfaction on participation in study and having atrial arrhythmia (AF) disorder, continuous participation in the follow-up were the others inclusion criteria.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Atrial fibrillation Rhythm. Timepoint: Before surgery, during g surgery every day in hospital, before discharge and 6 month after surgery. Method of measurement: ECG and Echocardiography.;The contractile function of heart. Timepoint: Before surgery, during g surgery every day in hospital, before discharge and 6 month after surgery. Method of measurement: ECG and Echocardiography.;Functional classification. Timepoint: Before surgery, during g surgery every day in hospital, before discharge and 6 month after surgery. Method of measurement: ECG and Echocardiography.

Secondary

MeasureTime frame
Af Rhythm 'cardiac contractile function. Timepoint: Before surgery , during g surgery every day in hospital ,before discharge and 6 month after surgery. Method of measurement: ECG and Echocardiography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Yaghoubi

Tabriz Universityof Medical Sciences

Yaghoubia@tbzmed.ac.ir; alireza_yaghoubi@yahoo.com+98 41 1335 7770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026